personalized liposomal neoantigen-based peptide vaccine EVX-01

{
  "id": "MLC-T-ONC-015975",
  "term": "personalized liposomal neoantigen-based peptide vaccine EVX-01",
  "field": "Oncology and biomedicine",
  "definition": "A personalized liposomal peptide vaccine composed of specific cancer neoepitopes, which are highly patient-specific immunogenic tumor associated antigens (TAAs), with potential immunostimulatory and antineoplastic activities. Upon administration of the personalized liposomal neoantigen-based peptide vaccine EVX-01, the neoepitopes induce cytotoxic T-lymphocyte (CTL)-mediated immune responses against tumor cells expressing these specific TAAs.",
  "synonyms": [
    "liposomal peptide-based vaccine EVX-01",
    "liposomal peptide vaccine EVX-01"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/personalized-liposomal-neoantigen-based-peptide-vaccine-evx-01/"
}